Publication | Open Access
Feasibility and safety of extended adjuvant temozolomide beyond six cycles for patients with glioblastoma
11
Citations
8
References
2017
Year
Extended cycles of temozolomide are safe and feasible for Chinese patients with disease responsive to temozolomide.
| Year | Citations | |
|---|---|---|
Page 1
Page 1